BiotechTube
Home/Nano Pharmasolutions/Sam Koh
SK

Sam Koh

CTO, Chief Technology Officer

Nano Pharmasolutions

Therapeutic Areas

Central Nervous System (CNS)Neurology

Nano Pharmasolutions Pipeline

DrugIndicationPhase
NT-301Neurological Disorder (Likely Parkinson's Disease)Phase 1
NT-401CNS DisorderPreclinical
NT-501CNS DisorderPreclinical

Leadership Team at Nano Pharmasolutions

KO
Kay Olmstead
CEO, Chief Executive Officer
JC
Justin Cho
Chief Business Officer
WM
William Martin
COO, Chief Operations Officer
SS
S. Shrewsbury
Chief Medical Officer
View full Nano Pharmasolutions profile